The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Metformin Protects Kidney Cells From Insulin-Mediated Genotoxicity In Vitro and in Male Zucker Diabetic Fatty Rats
Abstract
Hyperinsulinemia is thought to enhance cancer risk. A possible mechanism is induction of oxidative stress and DNA damage by insulin, Here, the effect of a combination of metformin with insulin was investigated in vitro and in vivo. The rationales for this were the reported antioxidative properties of metformin and the aim to gain further insights into the mechanisms responsible for protecting the genome from insulin-mediated oxidative stress and damage. The comet assay, a micronucleus frequency test, and a mammalian gene mutation assay were used to evaluate the DNA damage produced by insulin alone or in combination with metformin. For analysis of antioxidant activity, oxidative stress, and mitochondrial disturbances, the cell-free ferric reducing antioxidant power assay, the superoxide-sensitive dye dihydroethidium, and the mitochondrial membrane potential-sensitive dye 5,5',6,6'tetrachloro-1,1',3,3'-tetraethylbenzimidazol-carbocyanine iodide were applied. Accumulation of p53 and pAKT were analyzed. As an in vivo model, hyperinsulinemic Zucker diabetic fatty rats, additionally exposed to insulin during a hyperinsulinemic-euglycemic clamp, were treated with metformin. In the rat kidney samples, dihydroethidium staining, p53 and pAKT analysis, and quantification of the oxidized DNA base 8-oxo-7,8-dihydro-2'-deoxyguanosine were performed. Metformin did not show intrinsic antioxidant activity in the cell-free assay, but protected cultured cells from insulin-mediated oxidative stress, DNA damage, and mutation. Treatment of the rats with metformin protected their kidneys from oxidative stress and genomic damage induced by hyperinsulinemia. Metformin may protect patients from genomic damage induced by elevated insulin levels. This may support efforts to reduce the elevated cancer risk that is associated with hyperinsulinemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The genotoxicity-protective effects of metformin are demonstrated in human lymphocytes, normal and diabetic rats, rat and mouse bone marrow cells, mouse kidney cells as evidenced by a reduction in micronuclei and chromosomal aberrations”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Othman et al. 2016
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Benzie, I. F. F., & Strain, J. J. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)99005-5 · Cited by 3,929 · cited 1×
“Total antioxidant activity was measured according to (29).”
MethodMetformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · cited 1×
“Metformin is known to inhibit complex I of the mitochondrial respiratory chain I (15, 44).”
BackgroundMetformin—mode of action and clinical implications for diabetes and cancer
Pernicova, I., & Korbonits, M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.256 · Cited by 1,349 · cited 2×
“Metformin is known to inhibit complex I of the mitochondrial respiratory chain I (15, 44).”
BackgroundVigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
Role of oxidative stress and DNA damage in human carcinogenesis
Kryston, T. B., Georgiev, A. B., Pissis, P., & Georgakilas, A. G. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2010.12.016 · Cited by 930 · cited 2×
“As reviewed by Kryston et al (28), oxidative DNA damage is mutagenic and can lead to cancer induction.”
BackgroundAntidiabetic Therapies Affect Risk of Pancreatic Cancer
Li, D., Yeung, S. J., Hassan, M. M., Konopleva, M., & Abbruzzese, J. L. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.013 · Cited by 584
Cited by
Benefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766
“…are demonstrated in human lymphocytes, normal and diabetic rats, rat and mouse bone marrow cells, mouse kidney cells as evidenced by a reduction in micronuclei and chromosomal aberrations (Sant’Anna et al. 2013, Cheki et al. 2016, Othman et al. 2016, Najafi et al. 2018, Cheki et al. 2019).”
BackgroundMetformin: prevention of genomic instability and cancer: a review
Najafi, M., Cheki, M., Rezapoor, S., Geraily, G., Motevaseli, E., Carnovale, C., Clementi, E., & Shirazi, A. (2018) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2018.01.007 · Cited by 75
Metformin's Mechanisms in Attenuating Hallmarks of Aging and Age-Related Disease
Cheng, F., Liu, Y.-L., Du, J., & Lin, J. (2022) · Aging and Disease · doi:10.14336/ad.2021.1213 · Cited by 87
Potential effects of metformin in DNA BER system based on oxidative status in type 2 diabetes
Dogan Turacli, I., Candar, T., Yuksel, E. B., Kalay, S., Oguz, A. K., & Demirtas, S. (2018) · Biochimie · doi:10.1016/j.biochi.2018.08.002 · Cited by 46
Direct toxicity of insulin on the human placenta and protection by metformin
Vega, M., Mauro, M., & Williams, Z. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.032 · Cited by 41
Metadata
- Authors
- Othman, E. M., Oli, R. G., Arias-Loza, P.-A., Kreissl, M. C., & Stopper, H.
- Affiliations
- University of Würzburg (DE)
- Corresponding author
- Stopper, Helga
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2015-12-04
- Volume
- 157
- Issue
- 2
- Pages
- 548-559
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2186665901
- Cited by
- 23
- References
- 53
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 4 · 2018: 4
- FWCI
- 0.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- metformin, insulin, hyperinsulinemia, DNA damage, oxidative stress, genotoxicity, kidney, Zucker diabetic fatty rats, p53, Akt, 8-oxo-7,8-dihydro-2'-deoxyguanosine, cancer risk, mitochondrial membrane potential, antioxidant activity
- MeSH terms
- Animals, Antioxidants, Cells, Cultured, Diabetes Mellitus, Experimental, DNA Damage, Hyperinsulinism, Hypoglycemic Agents, Insulin, Kidney, Male, Metformin, Neoplasms, Rats, Zucker, Reactive Oxygen Species, Oxidative Stress, Cytoprotection, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metformin Protects Kidney Cells From Insulin-Mediated Genotoxicity In Vitro and in Male Zucker Diabetic Fatty Rats. https://app.cochat.ai/papers/10.1210/en.2015-1572
- The paper
- Othman, E. M., Oli, R. G., Arias-Loza, P.-A., Kreissl, M. C., & Stopper, H. (2016). Metformin Protects Kidney Cells From Insulin-Mediated Genotoxicity In Vitro and in Male Zucker Diabetic Fatty Rats. Endocrinology. https://doi.org/10.1210/en.2015-1572
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.